Guangyuyuan Chinese Herbal Medicine600771.SHValuation Analysis

As of Oct 19, 2026, Guangyuyuan Chinese Herbal Medicine (600771.SH) trades at a P/E of 96.00x, P/B of 4.07x, P/S of 4.12x, and a dividend yield of 0.00%.
Longitudinal percentile comparison: P/E sits at the 14th percentile over the trailing 10Y window (vs. 18th percentile over 3Y); P/B sits at the 19th percentile over the trailing 10Y window (vs. 12th percentile over 3Y); P/S sits at the 5th percentile over the trailing 10Y window (vs. 17th percentile over 3Y).
Cross-sectional valuation: its P/E ranks at the 80th percentile within its industry and the 79th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 0.00%; its historical percentile over the trailing long-term window is still accumulating data.
The P/E and P/B long-window percentiles differ by only 5.1 points, pointing to a consistent valuation read across both metrics. Its P/E percentile is roughly the same whether measured against the industry or the broader market. Shareholder returns here are driven almost entirely by cash dividends, with minimal contribution from buybacks. Guangyuyuan Chinese Herbal Medicine operates in the Medicine sector. Data refreshes weekly and is for reference only, not investment advice.